Sedation of Morbidly Obese for Balloon Insertion

Fentanyl Versus Ketamine Supplementation for Prpofol Anesthesia During Balloon Insertion in Morbidly Obese Patients

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03747094

Acronym

SedBaloon

Enrollment

Registered

2018-11-20

Start date

2018-12-01

Completion date

2019-04-15

Last updated

2018-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity

Brief summary

This prospective study will assess the value of different supplements to orpofol bases anesthesia in morbidly obes e patients scheduled for balloon insertion. Two common drugs will be added to propofol bases anesthesia;Ketamine or fentanyl. Effect on prpofol consumption, post-procedure recovery profile, and patient satisfaction will be the study objectives.

Interventions

DRUGFentanyl

0.5 mic/kg fentanyl will be given immediately before the procedure

DRUGKetamine

0.25 mg ketamine will be administered immediately before the procedure

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

20 Years to 45 Years

Healthy volunteers

Inclusion criteria

* morbid obese indicated for gastric balloon insertion

Exclusion criteria

\- Refusal Hypersensitivity to any of the study drugs

Design outcomes

Primary

Measure	Time frame	Description
Propofol consumption (milligrams)	24 hours after the endoscopy	Dose of prpofol (mg/kg) required for sedation during gastric balloon insertion

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026